PHAXIAM Therapeutics SA operates as a biopharmaceutical company. It engages in the development of treatments for resistant bacterial infections. The firm develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to combat bacterial infections in humans, particularly those resistant to antibiotics. The company was founded in 2004 and is headquartered in Lyon, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of PHAXIAM Therapeutics S.A. - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. PHAXIAM Therapeutics S.A. - ADR market cap is $31.16M.
What is the 52-week high for PHAXIAM Therapeutics S.A. - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. PHAXIAM Therapeutics S.A. - ADR 52 week high is $3.10 as of September 05, 2025.
What is the 52-week low for PHAXIAM Therapeutics S.A. - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PHAXIAM Therapeutics S.A. - ADR 52 week low is $3.10 as of September 05, 2025.
What is PHAXIAM Therapeutics S.A. - ADR stock price today?
PHAXIAM Therapeutics S.A. - ADR stock price today is $3.10.
What was PHAXIAM Therapeutics S.A. - ADR stock price yesterday?
PHAXIAM Therapeutics S.A. - ADR stock price yesterday was $3.12.
What is the PE ratio of PHAXIAM Therapeutics S.A. - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. PHAXIAM Therapeutics S.A. - ADR’s P/E ratio is -0.83.
What is the Price-to-Book ratio of PHAXIAM Therapeutics S.A. - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. PHAXIAM Therapeutics S.A. - ADR P/B ratio is 1.1372.
What is the 50-day moving average of PHAXIAM Therapeutics S.A. - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. PHAXIAM Therapeutics S.A. - ADR 50-day moving average is $3.10.
